First Eagle Investment Management, LLC Curis Inc Transaction History

First Eagle Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$0.78 - $2.01 $349,866 - $901,579	-448,547 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$0.62 - $2.25 $2.81 Million - $10.2 Million	-4,532,448 Reduced 90.99%	448,547 $309,000
Q2 2018 Aug 13, 2018	BUY	$1.73 - $3.35 $8.62 Million - $16.7 Million	4,980,995 New	4,980,995 $8.62 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $340M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.